Skip to main navigation Skip to search Skip to main content

An Interventional, Open-Label, Randomized, Multicenter Phase 2 Study of PF-07220060 Plus Letrozole Compared to Letrozole Alone in Postmenopausal Women 18 Years or Older With Hormone Receptor-Positive, HER2-Negative Breast Cancer in the Neoadjuvant Setting

  • Muttiah, Christine (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date5/12/24 → 5/12/26

Keywords

  • clinical trial
  • breast cancer
  • HER2 positive
  • LETROZOLE

Clinical Trial Phase

  • Phase II